These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17073825)

  • 1. Administration of brain natriuretic peptide improves cardiac function following operations using extracorporeal circulation in an animal model.
    Bail DH; Steger V; Heinzelmann U; Schiller S; Geim AI; Brüllmann B; Ziemer G
    Clin Sci (Lond); 2007 Mar; 112(5):315-24. PubMed ID: 17073825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide release in cardiac surgery patients.
    Sinha AM; Breithardt OA; Schmid M; Stellbrink C
    Thorac Cardiovasc Surg; 2005 Jun; 53(3):138-43. PubMed ID: 15926091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
    J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
    Xu XW; Zeng GY; Yang Y; Liu HX
    Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential renal protective benefits of intra-operative BNP infusion during cardiac transplantation.
    Zierer A; Voeller RK; Melby SJ; Kawa CB; Guthrie TJ; Baumgartner M; Pasque MK; Moon MR; Moazami N
    Transplant Proc; 2006 Dec; 38(10):3680-4. PubMed ID: 17175366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intact acute cardiorenal and humoral responsiveness following chronic subcutaneous administration of the cardiac peptide BNP in experimental heart failure.
    Chen HH; Schirger JA; Cataliotti A; Burnett JC
    Eur J Heart Fail; 2006 Nov; 8(7):681-6. PubMed ID: 16459135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential.
    Burger MR; Burger AJ
    Curr Opin Investig Drugs; 2001 Jul; 2(7):929-35. PubMed ID: 11757793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
    Vesely DL
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nesiritide: the latest drug for treating heart failure.
    Fontana D
    Crit Care Nurse; 2006 Feb; 26(1):39-44, 46-7. PubMed ID: 16443809
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A
    Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the effectiveness of toborinone (OPC-18790) in the treatment of heart failure in patients following cardiac surgery.
    Hirata T; Akamatsu T; Horinokuchi N; Uchida O; Kuro M
    Arzneimittelforschung; 1999 Jun; 49(6):499-503. PubMed ID: 10417865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in B-type natriuretic peptides after surgical ventricular restoration.
    Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
    Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain natriuretic peptide (BNP) in patients undergoing coronary artery bypass grafting.
    Bail DH; Kofler M; Ziemer G
    Thorac Cardiovasc Surg; 2004 Jun; 52(3):135-40. PubMed ID: 15192772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of B-type natriuretic peptide and effect of nesiritide after total cardiac replacement with the AbioCor total artificial heart.
    Delgado R; Wadia Y; Kar B; Ethridge W; Zewail A; Pool T; Myers TJ; Scroggins N; Frazier OH
    J Heart Lung Transplant; 2005 Aug; 24(8):1166-70. PubMed ID: 16102467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated natriuretic response to adrenomedullin in experimental heart failure.
    Jougasaki M; Heublein DM; Sandberg SM; Burnett JC
    J Card Fail; 2001 Mar; 7(1):75-83. PubMed ID: 11264553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betaxolol improves the survival rate and changes natriuretic peptide expression in rats with heart failure.
    Watanabe K; Juan W; Narasimman G; Ma M; Inoue M; Saito Y; Wahed MI; Nakazawa M; Hasegawa G; Naito M; Tachikawa H; Tanabe N; Kodama M; Aizawa Y; Yamamoto T; Yamaguchi K; Takahashi T
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S99-103. PubMed ID: 12693380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failure.
    Mulumba M; Céméus C; Dumont L; du Souich P; Ong H; Marleau S
    Growth Horm IGF Res; 2007 Apr; 17(2):96-103. PubMed ID: 17280860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dose the serum brain natriuretic peptide (BNP) level after open heart surgery reflect myocardial protection?].
    Shirasawa B; Hamano K; Kawamura T; Gohra H; Katoh T; Fujimura Y; Zempo N; Esato K
    Kyobu Geka; 2000 Feb; 53(2):123-6. PubMed ID: 10667022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.